Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry (Journal of Rheumatology (2013) 40, (74-9))
Zannin M. E.
•
Birolo C.
•
Gerloni V. M.
altro
Zulian F.
2013